AlexisJamieFeuerMD(She/Her)

[Pronunciation: FOY-UR]

Physician

Dr. Feuer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 2012 - 2015
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2009 - 2012
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2009

PubMed

35 citations
Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
Alexis J. Feuer, Ryan T. Demmer, Ashley Thai, Maria G. Vogiatzi
Bone. 2015-09-01
50 citations
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers.
Osagie Ebekozien, Shivani Agarwal, Nudrat Noor, Anastasia Albanese-O'Neill, Jenise C. Wong
The Journal of Clinical Endocrinology and Metabolism. 2021-03-25
29 citations
Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Alexis J. Feuer, Ashley Thai, Ryan T. Demmer, Maria G. Vogiatzi
JAMA Pediatrics. 2016-12-01

Black People with COVID-19 More Likely to Develop Diabetic KetoacidosisJanuary 7th, 2021
ENDO 2016: A Centennial CelebrationMay 7th, 2016
Stimulant Use for ADHD Associated with Lower Bone Density in Young PeopleApril 3rd, 2016
Join now to see all